Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for neurological use, Attention Deficit Hyperactivity Disorder, psychiatric diseases and disorders, all of which contain a compound that is a norepinephrine and dopamine-preferring triple reuptake inhibitor